Ozempic May Rewire the Brain, Changing Mood, Motivation and Cravings

New research suggests GLP-1 drugs like Ozempic—used for obesity and diabetes—may reshape brain networks and influence appetite, mood, cognition and addiction. Early brain scans in teens and young women on GLP-1s showed increased connectivity in the salience network within months, hinting at direct neural effects or indirect changes via gut-brain pathways. Scientists are exploring roles beyond weight loss, including potential impacts on anxiety, compulsive thinking and addiction, while noting that long-term, developmental effects (especially in adolescents) remain unclear. Although some trials hint at neuroprotective signals, a major Alzheimer’s trial with a related drug failed to slow cognitive decline, underscoring that conclusions about brain health from GLP-1s are still uncertain and ongoing.